Trials / Sponsors / Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D a Type2 Diabetes, NASH - Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis | Phase 3 | 2022-06-01 |
| Completed | A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, NASH - Nonalcoholic Steatohepatitis | Phase 2 | 2016-09-14 |